These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 32176787)
1. Association Between Pathophysiology and Volume of Distribution Among Patients With Sepsis or Septic Shock Treated With Imipenem: A Prospective Cohort Study. Huang Y; Yang J; Xie J; Liu L; Liu S; Guo F; Qiu H; Yang Y J Infect Dis; 2020 Mar; 221(Suppl 2):S272-S278. PubMed ID: 32176787 [TBL] [Abstract][Full Text] [Related]
2. Comparable Effect of Two-Step Versus Extended Infusions on the Pharmacokinetics of Imipenem in Patients with Sepsis and Septic Shock. Huang Y; Xu K; Zhan Y; Zha X; Liu S; Xie J; Liu L; Li Q; Shao H; Yang Y Adv Ther; 2020 May; 37(5):2246-2255. PubMed ID: 32277344 [TBL] [Abstract][Full Text] [Related]
3. [Lactic acid, lactate clearance and procalcitonin in assessing the severity and predicting prognosis in sepsis]. Zhao M; Duan M Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):449-453. PubMed ID: 32527351 [TBL] [Abstract][Full Text] [Related]
4. Vancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic Shock. Masich AM; Kalaria SN; Gonzales JP; Heil EL; Tata AL; Claeys KC; Patel D; Gopalakrishnan M Pharmacotherapy; 2020 Mar; 40(3):211-220. PubMed ID: 31957057 [TBL] [Abstract][Full Text] [Related]
5. [Clinical significance on serum intestinal fatty acid binding protein and D-lactic acid levels in early intestinal injury of patients with sepsis]. Zhang X; Liu D; Wang Y; Yan J; Yang X Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):545-550. PubMed ID: 31198137 [TBL] [Abstract][Full Text] [Related]
6. [Intestinal barrier dysfunction and its related factors in patients with sepsis]. Liu W; Wang XH; Yang XJ; Zhang XY; Qi WJ Zhonghua Yi Xue Za Zhi; 2016 Nov; 96(44):3568-3572. PubMed ID: 27916077 [No Abstract] [Full Text] [Related]
7. Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis. Novelli A; Adembri C; Livi P; Fallani S; Mazzei T; De Gaudio AR Clin Pharmacokinet; 2005; 44(5):539-49. PubMed ID: 15871639 [TBL] [Abstract][Full Text] [Related]
8. [Effect of Xuebijing on inflammatory response and prognosis in patients with septic shock]. Sun R; Liang M; Yang H; Liu Q; Ma N; Wei D; Dong F Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):458-462. PubMed ID: 32527353 [TBL] [Abstract][Full Text] [Related]
9. [Value of blood ammonia on predicting the severity and prognosis of patients with sepsis: a prospective observation study]. Gao C; Wang D; Li W; Guo X; Ma J; Xie Y Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Nov; 32(11):1315-1319. PubMed ID: 33463489 [TBL] [Abstract][Full Text] [Related]
10. Combination of Acute Physiology and Chronic Health Evaluation II score, early lactate area, and N-terminal prohormone of brain natriuretic peptide levels as a predictor of mortality in geriatric patients with septic shock. Wang H; Li Z; Yin M; Chen XM; Ding SF; Li C; Zhai Q; Li Y; Liu H; Wu DW J Crit Care; 2015 Apr; 30(2):304-9. PubMed ID: 25499413 [TBL] [Abstract][Full Text] [Related]
11. [Significance of high mobility group box 1, von Willebrand factor and other cytokines in the evaluation of severity and prognosis of sepsis patients]. Chen Y; Huang X; Kong G; Liu X; Tian H; Lyu B; Ning F; Wang T; Hao D Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Aug; 32(8):933-937. PubMed ID: 32912405 [TBL] [Abstract][Full Text] [Related]
12. Systemic and organ dysfunction response during infusion of recombinant human activated protein C (rhAPC) in severe sepsis and septic shock. Gullo A; Iscra F; Di Capua G; Berlot G; Lucangelo U; Peratoner A; Fasiolo S; Viviani M; Consales C; Zicari A Minerva Anestesiol; 2005 Dec; 71(12):785-801. PubMed ID: 16288186 [TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock. Artero A; Zaragoza R; Camarena JJ; Sancho S; González R; Nogueira JM J Crit Care; 2010 Jun; 25(2):276-81. PubMed ID: 20149587 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of the biomarkers serum amyloid A and nitric oxide in patients with sepsis. Yu MH; Chen MH; Han F; Li Q; Sun RH; Tu YX Int Immunopharmacol; 2018 Sep; 62():287-292. PubMed ID: 30048858 [TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients. Bai J; Wen A; Li Z; Li X; Duan M Eur J Hosp Pharm; 2024 Aug; 31(5):434-439. PubMed ID: 36948580 [TBL] [Abstract][Full Text] [Related]
16. Drug utilization pattern and cost for the treatment of severe sepsis and septic shock in critically ill cancer patients. Nazer L; Al-Shaer M; Hawari F Int J Clin Pharm; 2013 Dec; 35(6):1245-50. PubMed ID: 24104762 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of ADAMTS13 in patients with severe sepsis and septic shock. Azfar MF; Khan MF; Habib SS; Aseri ZA; Zubaidi AM; Aguila DO; Suriya MO; Ullah H Clin Invest Med; 2017 Apr; 40(2):E49-E58. PubMed ID: 28447577 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and Pharmacodynamic Efficacies of Continuous versus Intermittent Administration of Meropenem in Patients with Severe Sepsis and Septic Shock: A Prospective Randomized Pilot Study. Zhao HY; Gu J; Lyu J; Liu D; Wang YT; Liu F; Zhu FX; An YZ Chin Med J (Engl); 2017 May; 130(10):1139-1145. PubMed ID: 28485312 [TBL] [Abstract][Full Text] [Related]
19. [Clinical investigation on the risk factors for prognosis in patients with septic shock]. Yang B; Wang J; Tao X; Wang D Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1078-1082. PubMed ID: 31657328 [TBL] [Abstract][Full Text] [Related]
20. Heart-type fatty acid-binding protein as a prognostic factor in patients with severe sepsis and septic shock. Jo YH; Kim K; Lee JH; Rhee JE; Lee JH; Kang KW; Rim KP; Hwang SS; Park HM Am J Emerg Med; 2012 Nov; 30(9):1749-55. PubMed ID: 22463971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]